Investor directory

Jazz Venture Partners

Jazz Venture Partners is a San Francisco-based venture capital firm specializing in investments that enhance human performance through technology and neuroscience. The firm focuses on companies that utilize advanced brain science to develop impactful technology platforms, particularly in areas such as virtual and augmented reality, immersive gaming, artificial intelligence, and closed-loop human-computer systems. Their portfolio addresses significant markets including health, mind-body wellness, peak performance, accelerated learning, sports, and entertainment. The team comprises experienced investors, entrepreneurs, neuroscientists, and technologists, providing a wealth of domain expertise and access to innovative talent and resources. This diverse background enables them to effectively support exceptional entrepreneurs in building transformative companies.

Focus

Series AEarly VentureScale StageSeries BTherapeuticsShow more
http://jazzvp.com/
https://crunchbase.com/organization/jazz-venture-partners
https://linkedin.com/company/6584483
https://signal.nfx.com/firms/jazz-venture-partners
https://twitter.com/jazz_vp
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=316803079
https://www.privateequityinternational.com/database/#/profile?id=19370

Stone Connell

Vice President of Finance

Sydney Cureton

Senior Associate

Andrew Firlik

Managing Partner

Meghan Fitzpatrick

Associate

John F. Harris

Managing Partner

John Lee

Partner

Zack Lynch

Managing Partner

Meghan Reynolds

Partner

John Spinale

Managing Partner

Elan Tye

Principal

96 past transactions

Mahana Therapeutics

Series A in 2020
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

Level Ex

Series A in 2017
Level Ex is a developer of professional medical video games designed for physicians to capture the challenges of practicing medicine. The company uses state-of-the-art video game technology and cognitive neuroscience to capture the challenges of practicing medicine, allowing physicians to keep up-to-speed on rare and challenging cases, new medical devices and drug therapies.

Colossal Biosciences

Seed Round in 2021
Colossal is a ground-breaking bioscience and gene engineering firm that develops cutting-edge genomics technology.

Yumi

Series B in 2021
Yumi is the definitive source for parents seeking to understand what they are feeding their children and why, offering a science-based early childhood meal delivery program that is the most convenient and most nutritional option in the market.

Mediscope

Convertible Note in 2018
Wisdo is an award-winning social health platform designed to address the loneliness epidemic inflicting 3 of every 5 Americans and its negative impact on their social, emotional and physical health. Backed by research and driven by a proprietary AI engine, Wisdo instantly connects its users with people who have been in their shoes and are ready to listen and help. To date, over 1.4 million people have joined Wisdo to share their unique journeys, connect with others, set goals and track their progress towards happiness, success and fulfilment. Learn more at www.wisdo.com

The Meta

Series A in 2020
The Meta Game Inc. develops FPS training tools to improve all levels of gamers. It offers KovaaK that provides graphics, guided training, realistic weapons, target, dodging physics, user-defined profiles, performance analysis, and training and practice scenarios. The Meta Game Inc. was formerly known as TheMeta LLC. The company was incorporated in 2017 and is based in San Francisco, California.

KLOWEN Braces

Series A in 2022
KLOwen Braces, Inc. develops custom braces systems for orthodontists and the patients. The systems leverage a software platform that places the ideally shaped bracket for each tooth. It also offers brackets with hooks, bundles, tubes, and wires online. The company was incorporated in 2019 and is based in Fort Collins, Colorado.

Freeletics

Series B in 2020
Freeletics GmbH develops and operates software application for fitness. The company offers its application software for fitness, health, nutrition, sports, and workout. It provides nutrition coaching services through the application. The company also provides personalized training program by offering healthcare assessment and exercises. The company was founded in 2013 and is headquartered in Munich, Germany.

Sounding Board, Inc

Series B in 2021
Sounding Board Labs, Inc. develops a platform that offers coaching for leaders and new managers. Its platform creates personalized development plans, connects conveniently through phone, video, and chat, and provides executive coaching and provides qualified coaches. The company provides coaching plans, surveys, and reporting to show progress and results. Sounding Board Labs, Inc. was previously known as Sounding Board, Inc. Sounding Board Labs, Inc. was incorporated in 2016 and is headquartered in Aliso Viejo, California.

Augment AI Corp

Seed Round in 2022
Augment AI supercharge productivity and enables to free from the minutiae.

Freeletics

Series A in 2018
Freeletics GmbH develops and operates software application for fitness. The company offers its application software for fitness, health, nutrition, sports, and workout. It provides nutrition coaching services through the application. The company also provides personalized training program by offering healthcare assessment and exercises. The company was founded in 2013 and is headquartered in Munich, Germany.

NextStep

Seed Round in 2018
NextStep Interactive, Inc. offers training and job placement services. The company provides a mobile application that enables employers to screen talent based on the demonstration of competencies and soft skills suggestive of fit for health care professions. It assesses the skills and interests of the individual and matches it with the desired career option. The company also connects people with employers and offers placement opportunities. NextStep Interactive, Inc. was formerly known as NextStep Training Inc. The company was incorporated in 2017 and is based in Seattle, Washington with an additional office in Bozeman, Montana.

RxREVU, Inc.

Private Placement in 2019
RxREVU, Inc. provides medication savings dataset for healthcare applications, including transparency portals, insurance companies, and consumer mobile applications. Its cost-reduction strategies include therapeutic alternatives, splitting combination drugs, dividing high doses, generic substitutions, splitting pills, over the counter, quantity discounts, and more. The company serves consumers and businesses. RxREVU, Inc. was founded in 2013 and is based in Denver, Colorado.

Thrive

Series C in 2021
Thrive Global Holdings, Inc. provides behavior change programs. It offers a behavior change platform that combines data, stories, and actionable Microsteps. The company was incorporated in 2016 and is headquartered in New York, New York with an additional office in San Francisco, California.

Akili Interactive Labs

Series B in 2016
Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games. It aims to develop a new type of electronic medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches. Akili’s cognitive engine enables three separate clinical game versions for remote data-capture, with features designed for patient engagement. Its proprietary adaptive mechanics allow the software to automatically personalize to the patient’s ability level with no clinician input required. Akili is based in Boston, Massachusetts.

Swing Therapeutics

Seed Round in 2021
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

Level Ex

Seed Round in 2016
Level Ex is a developer of professional medical video games designed for physicians to capture the challenges of practicing medicine. The company uses state-of-the-art video game technology and cognitive neuroscience to capture the challenges of practicing medicine, allowing physicians to keep up-to-speed on rare and challenging cases, new medical devices and drug therapies.

Two Bit Circus

Series B in 2017
Two Bit Circus, Inc. is an entertainment company that invents and installs out-of-home physical amusement circus in California. It also offers Park as a Platform program to enable game developers to create location-based entertainment. The company features games, interactive amusement, stage shows, aerialists, food, and more. It also sells T-shirts, stickers, and clown noses online. The company was founded in 2012 and is headquartered in Los Angeles, California.

Akili Interactive Labs

Series C in 2018
Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games. It aims to develop a new type of electronic medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches. Akili’s cognitive engine enables three separate clinical game versions for remote data-capture, with features designed for patient engagement. Its proprietary adaptive mechanics allow the software to automatically personalize to the patient’s ability level with no clinician input required. Akili is based in Boston, Massachusetts.

Genesis Therapeutics

Series A in 2020
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction. The company was founded in 2019 and based in South San Francisco, California.

Pear Therapeutics

Series A in 2016
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Akili Interactive Labs

Private Placement in 2018
Akili builds clinically-validated cognitive therapeutics, assessments, and diagnostics that look and feel like video games. It aims to develop a new type of electronic medicine that can be deployed remotely directly to any patient anywhere, prescribed and tracked by physicians, with the potential to be developed at a fraction of the cost of traditional medical approaches. Akili’s cognitive engine enables three separate clinical game versions for remote data-capture, with features designed for patient engagement. Its proprietary adaptive mechanics allow the software to automatically personalize to the patient’s ability level with no clinician input required. Akili is based in Boston, Massachusetts.

RxREVU, Inc.

Series B in 2021
RxREVU, Inc. provides medication savings dataset for healthcare applications, including transparency portals, insurance companies, and consumer mobile applications. Its cost-reduction strategies include therapeutic alternatives, splitting combination drugs, dividing high doses, generic substitutions, splitting pills, over the counter, quantity discounts, and more. The company serves consumers and businesses. RxREVU, Inc. was founded in 2013 and is based in Denver, Colorado.

Thrive

Private Placement in 2019
Thrive Global Holdings, Inc. provides behavior change programs. It offers a behavior change platform that combines data, stories, and actionable Microsteps. The company was incorporated in 2016 and is headquartered in New York, New York with an additional office in San Francisco, California.

Cadence Neuroscience

Series A in 2019
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Mahana Therapeutics

Seed Round in 2020
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

Outside

Private Placement in 2020
Pocket Outdoor Media brands influence and engage more athletes than any other through a combined print, online, and social audience of millions of runners, cyclists, triathletes, and swimmers. It features bike racing media brand triathlete and Women’s Running focusing on resource for women runners;

Pear Therapeutics

Series B in 2018
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Cadence Neuroscience

Private Placement in 2019
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Pymetrics

Series A in 2017
Pymetrics develops neuroscience-based assessment and prediction technology to transform the way companies hire, retain, and develop their employees. It offers cognitive and emotional assessment solutions; and a personalized and dynamic recommendation engine for recruiting/hiring, retaining, and developing talent. Frida E. Polli and Julie Yoo founded Pymetrics in September 2013. Its headquarters is in New York City.

Eyefluence

Series B in 2015
Eyefluence, Inc. develops an eye-interaction technology solution for controlling augmented reality AR, virtual reality VR, and mixed reality MR head-mounted display HMD equipment with eyes. Its technology integrates with HMDs, as well as combines with eye biomechanics, a deep understanding of the eye-brain connection to deliver fastest interface for HMDs. It serves AR, VR, and MR device manufacturers. The company was founded in 2013 and is headquartered in Reno, Nevada. As of October 24, 2016, Eyefluence, Inc. operates as a subsidiary of Google Inc.

Cadence Neuroscience

Venture Round in 2023
Cadence Neuroscience is an early-stage company developing new medical device therapies for the treatment of epilepsy, central pain, and other neurological disorders. The company's core technology has been developed at Mayo Clinic and is under clinical evaluation. Its medical device therapies provide medical practitioners with the procedure that can be used to tailor brain stimulation therapy to each individual and enhance seizure control compared to currently used protocols. Cadence Neuroscience was established in 2017 and is headquartered in Redmond, Washington.

Colossal Biosciences

Series B in 2023
Colossal is a ground-breaking bioscience and gene engineering firm that develops cutting-edge genomics technology.

Cabservices24x7

Series A in 2022
Form Bio is a biotech company that provides solutions to address the data, computational, and technical hurdles in the life sciences. Founded in 2022, the company is based in Austin, Texas, United States.

Augment CXM

Seed Round in 2017
Augment Solutions, Inc. develops and offers customer experience platform based on Artificial Intelligence (AI). The company develops machine learning based live chat and messaging applications which enable brand representatives to deliver customer service. It also offers Product Helper, an application that integrates existing product inventory management catalog and brings suggested products to the agent’s console. Augment Solutions, Inc. was founded in 2017 and is based in San Francisco, California.

Outside

Series A in 2020
Pocket Outdoor Media brands influence and engage more athletes than any other through a combined print, online, and social audience of millions of runners, cyclists, triathletes, and swimmers. It features bike racing media brand triathlete and Women’s Running focusing on resource for women runners;

Perceptive Automata

Private Placement in 2018
Perceptive Automata, Inc. develops machine learning and computer vision solutions. Its solutions are used in the automated vehicles to understand what people might do next, so solutions can navigate around humans, including pedestrians, cyclists, and other drivers. The company was incorporated in 2014 and is based in Somerville, Massachusetts.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy organizations to provide prescriptions to any patient using their mobile devices. Blue Note Therapeutics was founded in 2018 and is based in San Francisco, California.

Freeletics

Private Placement in 2018
Freeletics GmbH develops and operates software application for fitness. The company offers its application software for fitness, health, nutrition, sports, and workout. It provides nutrition coaching services through the application. The company also provides personalized training program by offering healthcare assessment and exercises. The company was founded in 2013 and is headquartered in Munich, Germany.

Pear Therapeutics

Series D in 2020
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Zeitworks

Seed Round in 2020
Zeitworks Technologies, Inc. develops software-as-a-service (SaaS) platform for business process improvement. The application leverages machine learning to discover, analyze, and improve customers’ business processes. It discovers and measures business process execution step-by-step through the paths workers take in the course of ordinary work. The company was incorporated in 2020 and is based in Seattle, Washington with an additional office in Los Angeles, California.

HerMD

Series A in 2022
HERmd is a provider of female comprehensive health, beauty, and wellness services. From gynecology and menopause to sexual medicine and medical aesthetics, the company provides a safe, trusted space to address all of the client's needs, no matter how personal. HERmd was founded by Somi Javaid in 2019 and is headquartered in Cincinnati, Ohio,

Woebot Health

Series A in 2018
Woebot Health’s mission is to make mental health radically accessible. Our breakthrough technology is engineered to engage, bringing the art and science of effective therapy together in a suite of digital therapeutics and behavioral health products that are related, responsive and targeted, Headquartered in San Francisco, Woebot Health is funded in part by venture capital firms New Enterprise Associates (NEA), Jazz Venture Partners L.P., and Social Discovery Ventures, with participation from Andrew Ng’s AI Fund.

Thrive

Series B in 2018
Thrive Global Holdings, Inc. provides behavior change programs. It offers a behavior change platform that combines data, stories, and actionable Microsteps. The company was incorporated in 2016 and is headquartered in New York, New York with an additional office in San Francisco, California.

Oma Fertility

Venture Round in 2022
Oma Fertility is a full-service fertility clinic that offers fertility care and treatments. It brings top lab design and technology to in-house treatments like IUI and IVF, coordinates seamlessly with third parties like surrogate agencies and egg and sperm banks Oma uses Oma Sperm InSight and their proprietary AI microscope, which together help their embryologists select the most promising sperm cell for IVF.

Zeitworks

Venture Round in 2021
Zeitworks Technologies, Inc. develops software-as-a-service (SaaS) platform for business process improvement. The application leverages machine learning to discover, analyze, and improve customers’ business processes. It discovers and measures business process execution step-by-step through the paths workers take in the course of ordinary work. The company was incorporated in 2020 and is based in Seattle, Washington with an additional office in Los Angeles, California.

Pear Therapeutics

Private Placement in 2020
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Outside

Series B in 2021
Pocket Outdoor Media brands influence and engage more athletes than any other through a combined print, online, and social audience of millions of runners, cyclists, triathletes, and swimmers. It features bike racing media brand triathlete and Women’s Running focusing on resource for women runners;

AppliedVR

Series B in 2021
AppliedVR, Inc. provides a virtual reality platform for enhanced patient experience in healthcare around pain and anxiety management in hospitals, surgery centers, and exam rooms in the United States. AppliedVR, Inc. has strategic partnerships with Cedars-Sinai and Children's Hospital Los Angeles. The company was founded in 2013 and is based in Los Angeles, California.

Magnus Medical

Series A in 2020
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.

Halo Neuro Inc.

Private Placement in 2018
Halo Neuro Inc. develops a system that uses light electric stimulation to induce a state of hyperplasticity in the brain utilizing a specially designed device. It offers its product for athletes, elite teams, and organizations. The company was incorporated in 2013 and is based in San Francisco, California.

Woebot Health

Series B in 2021
Woebot Health’s mission is to make mental health radically accessible. Our breakthrough technology is engineered to engage, bringing the art and science of effective therapy together in a suite of digital therapeutics and behavioral health products that are related, responsive and targeted, Headquartered in San Francisco, Woebot Health is funded in part by venture capital firms New Enterprise Associates (NEA), Jazz Venture Partners L.P., and Social Discovery Ventures, with participation from Andrew Ng’s AI Fund.

Colossal Biosciences

Series A in 2022
Colossal is a ground-breaking bioscience and gene engineering firm that develops cutting-edge genomics technology.

JobGet

Series B in 2022
JOBGET INC. operates a mobile hiring application and job search platform. The company’s platform creates a marketplace where employers and job seekers can message each other, schedule meetings, and conduct video interviews. The company was incorporated in 2017 and is based in Boston, Massachusetts.

NextStep

Private Placement in 2019
NextStep Interactive, Inc. offers training and job placement services. The company provides a mobile application that enables employers to screen talent based on the demonstration of competencies and soft skills suggestive of fit for health care professions. It assesses the skills and interests of the individual and matches it with the desired career option. The company also connects people with employers and offers placement opportunities. NextStep Interactive, Inc. was formerly known as NextStep Training Inc. The company was incorporated in 2017 and is based in Seattle, Washington with an additional office in Bozeman, Montana.

Swing Therapeutics

Series A in 2022
Swing is creating the next generation of safe and effective digital therapeutics for people with chronic conditions. Our team of passionate scientists, clinicians, and technologists are partnering with some of the world’s top researchers to develop evidence-based transformative digital treatments. Swing’s solutions empower patients to regain control of their illnesses. Together, we are helping people achieve improved health so that they can lead more joyful, vibrant lives.

AllStripes

Series B in 2021
AllStripes is a healthcare technology company dedicated to unlocking new treatments for people with rare disease. AllStripes has developed a two-sided platform that empowers patients to access and benefit from their own medical records and generates regulatory-ready evidence for life sciences companies.

Genesis Therapeutics

Private Placement in 2020
Their academia-leading research was the initial component of our expanding portfolio of AI technologies. They are combining novel deep neural networks, biophysical simulation, and massively scalable computing infrastructure to achieve industry-leading performance in a molecular generation and property prediction. The company was founded in 2019 and based in South San Francisco, California.

NextStep

Venture Round in 2021
NextStep Interactive, Inc. offers training and job placement services. The company provides a mobile application that enables employers to screen talent based on the demonstration of competencies and soft skills suggestive of fit for health care professions. It assesses the skills and interests of the individual and matches it with the desired career option. The company also connects people with employers and offers placement opportunities. NextStep Interactive, Inc. was formerly known as NextStep Training Inc. The company was incorporated in 2017 and is based in Seattle, Washington with an additional office in Bozeman, Montana.

Blue Note Therapeutics

Series A in 2021
Blue Note Therapeutics is a prescription digital therapeutics company that merges deep scientific and clinical expertise. The company works with medical researchers and patient advocacy organizations to provide prescriptions to any patient using their mobile devices. Blue Note Therapeutics was founded in 2018 and is based in San Francisco, California.

Mahana Therapeutics

Series B in 2021
Mahana Therapeutics, Inc. develops an application for treating patients suffering from gastrointestinal (GI) diseases and conditions. The company offers Parallel, a clinically-validated and minimal-contact digital program for people with irritable bowel syndrome (IBS). Mahana Therapeutics, Inc. was formerly known as Mahana Health, Inc. and changed its name to Mahana Therapeutics, Inc. in July 2019. The company was incorporated in 2018 and is based in San Francisco, California. It has an additional location in London, United Kingdom.

NextStep

Series A in 2019
NextStep Interactive, Inc. offers training and job placement services. The company provides a mobile application that enables employers to screen talent based on the demonstration of competencies and soft skills suggestive of fit for health care professions. It assesses the skills and interests of the individual and matches it with the desired career option. The company also connects people with employers and offers placement opportunities. NextStep Interactive, Inc. was formerly known as NextStep Training Inc. The company was incorporated in 2017 and is based in Seattle, Washington with an additional office in Bozeman, Montana.

AppliedVR

Series A in 2021
AppliedVR, Inc. provides a virtual reality platform for enhanced patient experience in healthcare around pain and anxiety management in hospitals, surgery centers, and exam rooms in the United States. AppliedVR, Inc. has strategic partnerships with Cedars-Sinai and Children's Hospital Los Angeles. The company was founded in 2013 and is based in Los Angeles, California.

Magnus Medical

Series A in 2021
Magnus Medical develops a closed-loop neuromodulation technology to effectively treat intractable neurological and psychiatric disorders.

NextStep

Private Placement in 2020
NextStep Interactive, Inc. offers training and job placement services. The company provides a mobile application that enables employers to screen talent based on the demonstration of competencies and soft skills suggestive of fit for health care professions. It assesses the skills and interests of the individual and matches it with the desired career option. The company also connects people with employers and offers placement opportunities. NextStep Interactive, Inc. was formerly known as NextStep Training Inc. The company was incorporated in 2017 and is based in Seattle, Washington with an additional office in Bozeman, Montana.

Freeletics

Private Placement in 2020
Freeletics GmbH develops and operates software application for fitness. The company offers its application software for fitness, health, nutrition, sports, and workout. It provides nutrition coaching services through the application. The company also provides personalized training program by offering healthcare assessment and exercises. The company was founded in 2013 and is headquartered in Munich, Germany.

Robust.AI

Series A in 2020
Robust AI, Inc. develops a industrial-grade cognitive platform that brings common sense reasoning to robots. The company was founded in 2019 and is based in Palo Alto, California.

NextStep

Venture Round in 2021
NextStep Interactive, Inc. offers training and job placement services. The company provides a mobile application that enables employers to screen talent based on the demonstration of competencies and soft skills suggestive of fit for health care professions. It assesses the skills and interests of the individual and matches it with the desired career option. The company also connects people with employers and offers placement opportunities. NextStep Interactive, Inc. was formerly known as NextStep Training Inc. The company was incorporated in 2017 and is based in Seattle, Washington with an additional office in Bozeman, Montana.

Halo Neuroscience

Series B in 2018
Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes. Neuropriming is the process of using electrical stimulation during movement-based training to build stronger, more optimized connections between your brain and muscles. This process induces a temporary state of hyper-learning or "hyperplasticity" in the brain, which refines the brain's ability to learn and adapt to training. The company was incorporated in 2013 and is based in San Francisco, CA.

Pear Therapeutics

Private Placement in 2018
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Perceptive Automata

Series A in 2018
Perceptive Automata, Inc. develops machine learning and computer vision solutions. Its solutions are used in the automated vehicles to understand what people might do next, so solutions can navigate around humans, including pedestrians, cyclists, and other drivers. The company was incorporated in 2014 and is based in Somerville, Massachusetts.

NextStep

Venture Round in 2020
NextStep Interactive, Inc. offers training and job placement services. The company provides a mobile application that enables employers to screen talent based on the demonstration of competencies and soft skills suggestive of fit for health care professions. It assesses the skills and interests of the individual and matches it with the desired career option. The company also connects people with employers and offers placement opportunities. NextStep Interactive, Inc. was formerly known as NextStep Training Inc. The company was incorporated in 2017 and is based in Seattle, Washington with an additional office in Bozeman, Montana.

Embodied

Private Placement in 2018
Embodied is an AI company that develops state-of-the-art companion robots that aim to revolutionize care and wellness, enhancing the quality of life for individuals and families. They are combining 14 years of research in socially assistive robotics from the University of Southern California with 15 years of experience with commercialization of consumer robotics from iRobot, and decades of animation and storytelling to build life-like, interactive robots to serve as motivators, coaches, and companions that help and empower people to be better at helping themselves.

Pear Therapeutics

Series C in 2019
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.

Freeletics

Venture Round in 2018
Freeletics GmbH develops and operates software application for fitness. The company offers its application software for fitness, health, nutrition, sports, and workout. It provides nutrition coaching services through the application. The company also provides personalized training program by offering healthcare assessment and exercises. The company was founded in 2013 and is headquartered in Munich, Germany.

Embodied

Series A in 2018
Embodied is an AI company that develops state-of-the-art companion robots that aim to revolutionize care and wellness, enhancing the quality of life for individuals and families. They are combining 14 years of research in socially assistive robotics from the University of Southern California with 15 years of experience with commercialization of consumer robotics from iRobot, and decades of animation and storytelling to build life-like, interactive robots to serve as motivators, coaches, and companions that help and empower people to be better at helping themselves.

Zeitworks

Private Placement in 2020
Zeitworks Technologies, Inc. develops software-as-a-service (SaaS) platform for business process improvement. The application leverages machine learning to discover, analyze, and improve customers’ business processes. It discovers and measures business process execution step-by-step through the paths workers take in the course of ordinary work. The company was incorporated in 2020 and is based in Seattle, Washington with an additional office in Los Angeles, California.

RxREVU, Inc.

Series A in 2019
RxREVU, Inc. provides medication savings dataset for healthcare applications, including transparency portals, insurance companies, and consumer mobile applications. Its cost-reduction strategies include therapeutic alternatives, splitting combination drugs, dividing high doses, generic substitutions, splitting pills, over the counter, quantity discounts, and more. The company serves consumers and businesses. RxREVU, Inc. was founded in 2013 and is based in Denver, Colorado.

Wade & Wendy

Private Placement in 2019
Wade & Wendy, Inc. develops a software that assists in hiring process. The company develops Wendy, a chatbot for employers that screens applicants on a career website and makes recommendations; and Wade, a chatbot for applicants that uses artificial intelligence (AI) to record the data and find jobs. Wade & Wendy, Inc. was formerly known as Wecrewt, Inc. The company was incorporated in 2015 and is based in New York, New York.

Halo Neuroscience

Series A in 2016
Halo Neuroscience develops and markets neurotechnology systems to help individuals unlock their true potential. Their first product, Halo Sport, utilizes Neuropriming technology to accelerate skill and strength acquisition in elite athletes. Neuropriming is the process of using electrical stimulation during movement-based training to build stronger, more optimized connections between your brain and muscles. This process induces a temporary state of hyper-learning or "hyperplasticity" in the brain, which refines the brain's ability to learn and adapt to training. The company was incorporated in 2013 and is based in San Francisco, CA.

AIR (AI Redefined)

Seed Round in 2018
AIR is a software company specialized in machine learning research and applications. Its vision is to build a brighter, smarter future by improving the synergy between people and AI; its mission, to provide a universal and safe digital place where AIs and people can learn continuously from each other. Its first product, Cogment (https://cogment.ai), is a high-performance, open source framework that allows multi-agent, multi-reward, continuous live training of AIs and Humans together in the same environment.

Robust.AI

Private Placement in 2020
Robust AI, Inc. develops a industrial-grade cognitive platform that brings common sense reasoning to robots. The company was founded in 2019 and is based in Palo Alto, California.

Aira

Series B in 2017
Aira Tech Corp. provides an online platform that operates as a visual interpreter and navigator for blind and low-vision users. Its platform enables orientation and mobility experts, such as trained agents, family members, or friends to provide virtual personal assistance by integrating smart glasses with the user's smartphone. The company was formerly known as Kast Inc. Aira Tech Corp. was incorporated in 2015 and is based in La Jolla, California.

Pymetrics

Series B in 2018
Pymetrics develops neuroscience-based assessment and prediction technology to transform the way companies hire, retain, and develop their employees. It offers cognitive and emotional assessment solutions; and a personalized and dynamic recommendation engine for recruiting/hiring, retaining, and developing talent. Frida E. Polli and Julie Yoo founded Pymetrics in September 2013. Its headquarters is in New York City.

HerMD

Series A in 2023
HERmd is a provider of female comprehensive health, beauty, and wellness services. From gynecology and menopause to sexual medicine and medical aesthetics, the company provides a safe, trusted space to address all of the client's needs, no matter how personal. HERmd was founded by Somi Javaid in 2019 and is headquartered in Cincinnati, Ohio,

Robust.AI

Series A in 2023
Robust AI, Inc. develops a industrial-grade cognitive platform that brings common sense reasoning to robots. The company was founded in 2019 and is based in Palo Alto, California.

Enveda Biosciences

Series B in 2022
Enveda Therapeutics is constructing and decoding the largest integrated dataset of anthropological, biological, and chemical information from medicinal plants to inspire new medicines.

Zus Health

Series A in 2023
Zus Health helps a new wave of healthcare builders to create technologies and services without the usual blockers. Zus Health aims to bring forth a better health reality by empowering an inspired new wave of healthcare builders to create digital technologies and services that are cheaper, easier to customize, and far more intimate.

Enveda Biosciences

Series B in 2024
Enveda Therapeutics is constructing and decoding the largest integrated dataset of anthropological, biological, and chemical information from medicinal plants to inspire new medicines.